escalation and deescalation antiplatelet dr. Personaldi, Invasive club.pptx

cardiology and vascular medicine

1. Invasive club Switching antiplatelet in ACS patient Mentor: Dr. dr. Nahar Taufiq, Sp.JP(K)

2. Introduction Dual antiplatelet therapy (DAPT) cornerstone in ACS or undergoing percutaneous coronary intervention (PCI) In patients with ACS, current guidelines recommend 12 months of DAPT with aspirin and an oral P2Y12 receptor inhibitor (preferably ticagrelor or prasugrel over clopidogrel). DAPT duration is usually tailored to the individual risk: if patients are deemed at high bleeding risk, then DAPT duration can be shortened by up to 1 month in the case of both ACS or elective PCI; conversely, in case of low bleeding risk and high ischemic risk, DAPT can be prolonge beyond 12 months

3. Thank You